Comparison of modification sites formed on human serum albumin at various stages of glycation.

BACKGROUND Many of the complications encountered during diabetes can be linked to the non-enzymatic glycation of proteins, including human serum albumin (HSA). However, there is little information regarding how the glycation pattern of HSA changes as the total extent of glycation is varied. The goal of this study was to identify and conduct a semi-quantitative comparison of the glycation products on HSA that are produced in the presence of various levels of glycation. METHODS Three glycated HSA samples were prepared in vitro by incubating physiological concentrations of HSA with 15 mmol/l glucose for 2 or 5 weeks, or with 30 mmol/l glucose for 4 weeks. These samples were then digested and examined by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) to identify the glycation products that were formed. RESULTS It was found that the glycation pattern of HSA changed with its overall extent of total glycation. Many modifications including previously-reported primary glycation sites (e.g., K199, K281, and the N-terminus) were consistently found in the tested samples. Lysines 199 and 281, as well as arginine 428, contained the most consistently identified and abundant glycation products. Lysines 93, 276, 286, 414, 439, and 524/525, as well as the N-terminus and arginines 98, 197, and 521, were also found to be modified at various degrees of HSA glycation. CONCLUSIONS The glycation pattern of HSA was found to vary with different levels of total glycation and included modifications at the 2 major drug binding sites on this protein. This result suggests that different modified forms of HSA, both in terms of the total extent of glycation and glycation pattern, may be found at various stages of diabetes. The clinical implication of these results is that the binding of HSA to some drug may be altered at various stages of diabetes as the extent of glycation and types of modifications in this protein are varied.

[1]  R. Flückiger,et al.  Nonenzymatic glycosylation of albumin in vivo. Identification of multiple glycosylated sites. , 1986, The Journal of biological chemistry.

[2]  D. S. Hage,et al.  Obtaining high sequence coverage in matrix-assisted laser desorption time-of-flight mass spectrometry for studies of protein modification: analysis of human serum albumin as a model. , 2006, Analytical biochemistry.

[3]  N. Turk,et al.  Temporal association between lens protein glycation and cataract development in diabetic rats , 1997, Acta Diabetologica.

[4]  V. Monnier,et al.  Accelerated age-related browning of human collagen in diabetes mellitus. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[5]  S. Curry,et al.  Structural basis of the drug-binding specificity of human serum albumin. , 2005, Journal of molecular biology.

[6]  Paul J Thornalley.  Dicarbonyl Intermediates in the Maillard Reaction , 2005, Annals of the New York Academy of Sciences.

[7]  P. Brick,et al.  Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites , 1998, Nature Structural Biology.

[8]  Jansirani,et al.  A comparative study of lens protein glycation in various forms of cataract , 2008, Indian Journal of Clinical Biochemistry.

[9]  Yinong Zhang,et al.  Rapid determination of advanced glycation end products of proteins using MALDI-TOF-MS and PERL script peptide searching algorithm. , 2003, Journal of biomolecular techniques : JBT.

[10]  T. Peters,et al.  All About Albumin: Biochemistry, Genetics, and Medical Applications , 1995 .

[11]  R. Bank,et al.  Ageing and zonal variation in post-translational modification of collagen in normal human articular cartilage. The age-related increase in non-enzymatic glycation affects biomechanical properties of cartilage. , 1998, The Biochemical journal.

[12]  K Schulten,et al.  VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.

[13]  Paul J Thornalley,et al.  Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. , 1999, The Biochemical journal.

[14]  D. Robb,et al.  Identification of glycation at the N-terminus of albumin by gas chromatography-mass spectrometry. , 1989, The Biochemical journal.

[15]  Domenico Fedele,et al.  Enzymatic digestion and mass spectrometry in the study of advanced glycation end products/peptides , 2004, Journal of the American Society for Mass Spectrometry.

[16]  I. Syrový.  Glycation of albumin: reaction with glucose, fructose, galactose, ribose or glyceraldehyde measured using four methods. , 1994, Journal of biochemical and biophysical methods.

[17]  Y. Oiso,et al.  Antiglycation effect of gliclazide on in vitro AGE formation from glucose and methylglyoxal. , 2008, Experimental biology and medicine.

[18]  R. Khalifah,et al.  Modification of Proteins In Vitro by Physiological Levels of Glucose , 2003, Journal of Biological Chemistry.

[19]  D A Armbruster,et al.  Fructosamine: structure, analysis, and clinical usefulness. , 1987, Clinical chemistry.

[20]  H. Chandalia,et al.  Glycated Hemoglobin , 2020 .

[21]  D. S. Hage,et al.  Quantitative analysis of glycation sites on human serum albumin using (16)O/(18)O-labeling and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. , 2010, Clinica chimica acta; international journal of clinical chemistry.

[22]  D. S. Hage,et al.  Chromatographic analysis of acetohexamide binding to glycated human serum albumin. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[23]  S. Pizzo,et al.  The standardization of the thiobarbituric acid assay for nonenzymatic glucosylation of human serum albumin. , 1981, Analytical biochemistry.

[24]  F. Rodkey.  DIRECT SPECTROPHOTOMETRIC DETERMINATION OF ALBUMIN IN HUMAN SERUM. , 1965, Clinical chemistry.

[25]  Toru Maruyama,et al.  The effect of glycation on the structure, function and biological fate of human serum albumin as revealed by recombinant mutants. , 2003, Biochimica et biophysica acta.

[26]  Jan H. Jensen,et al.  Very fast empirical prediction and rationalization of protein pKa values , 2005, Proteins.

[27]  D. S. Hage,et al.  The effects of glycation on the binding of human serum albumin to warfarin and L-tryptophan. , 2010, Journal of pharmaceutical and biomedical analysis.

[28]  S. Catinella,et al.  A new effective method for the evaluation of glycated intact plasma proteins in diabetic subjects , 1995, Diabetologia.

[29]  J. Harding,et al.  The effects of aminoguanidine on the glycation (non-enzymic glycosylation) of lens proteins. , 1990, Experimental eye research.

[30]  V. Monnier,et al.  Partial characterization of the molecular nature of collagen-linked fluorescence: role of diabetes and end-stage renal disease. , 2010, Archives of biochemistry and biophysics.

[31]  Paul J Thornalley,et al.  Peptide Mapping Identifies Hotspot Site of Modification in Human Serum Albumin by Methylglyoxal Involved in Ligand Binding and Esterase Activity* , 2005, Journal of Biological Chemistry.

[32]  David S. Wishart,et al.  VADAR: a web server for quantitative evaluation of protein structure quality , 2003, Nucleic Acids Res..

[33]  A. Shimizu,et al.  Quantification of glycated hemoglobin by electrospray ionization mass spectrometry. , 1997, Journal of mass spectrometry : JMS.

[34]  J. Duarte,et al.  Involvement of advanced glycation end products in the pathogenesis of diabetic complications: the protective role of regular physical activity , 2008, European Review of Aging and Physical Activity.

[35]  M. Mann,et al.  On the Proper Use of Mass Accuracy in Proteomics* , 2007, Molecular & Cellular Proteomics.

[36]  P. Raskin,et al.  Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.

[37]  M. Saito,et al.  Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus , 2010, Osteoporosis International.

[38]  A. O. Pedersen,et al.  Calcium ion binding to clinically relevant chemical modifications of human serum albumin. , 1995, Clinical chemistry.

[39]  K. Kobayashi,et al.  Crystal structure of human serum albumin at 2.5 A resolution. , 1999, Protein engineering.

[40]  H. Bunn,et al.  Nonenzymatic glycosylation of human serum albumin alters its conformation and function. , 1984, The Journal of biological chemistry.

[41]  R. Holman,et al.  Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. , 1999, JAMA.

[42]  M. Ganjali,et al.  Spectroscopic studies of the effects of glycation of human serum albumin on L-Trp binding. , 2007, Protein and peptide letters.

[43]  G. Hue,et al.  Protein binding of digitoxin, valproate and phenytoin in sera from diabetics , 2004, European Journal of Clinical Pharmacology.

[44]  D. S. Hage,et al.  Binding of tolbutamide to glycated human serum albumin. , 2011, Journal of pharmaceutical and biomedical analysis.

[45]  R. Bucala,et al.  Immunochemical detection of advanced glycosylation end products in vivo. , 1992, The Journal of biological chemistry.

[46]  Q. Smith,et al.  Role of Site-Specific Binding to Plasma Albumin in Drug Availability to Brain , 2006, Journal of Pharmacology and Experimental Therapeutics.

[47]  K. Tomer,et al.  Effect of nonenzymatic glycation of albumin and superoxide dismutase by glucuronic acid and suprofen acyl glucuronide on their functions in vitro. , 1999, Chemico-biological interactions.

[48]  M. Namiki,et al.  Formation of Three-carbon Sugar Fragment at an Early Stage of the Browning Reaction of Sugar with Amines or Amino Acids , 1986 .

[49]  D. N. Perkins,et al.  Probability‐based protein identification by searching sequence databases using mass spectrometry data , 1999, Electrophoresis.

[50]  Qibin Zhang,et al.  A perspective on the Maillard reaction and the analysis of protein glycation by mass spectrometry: probing the pathogenesis of chronic disease. , 2009, Journal of proteome research.

[51]  A. Urbani,et al.  A quantitative method for the analysis of glycated and glutathionylated hemoglobin by matrix-assisted laser desorption ionization-time of flight mass spectrometry. , 2005, Analytical biochemistry.

[52]  D. S. Hage,et al.  Characterization of glycation adducts on human serum albumin by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[53]  Y. Oiso,et al.  A BRIEF COMMUNICATION , 2008 .

[54]  Rury R. Holman,et al.  Glycemic Control with Diet, Sulfonylurea, Metformin, or Insulin in Patients with Type 2 Diabetes Mellitus: Progressive Requirement for Multiple Therapies (UKPDS 49) , 1999 .

[55]  A. Uno,et al.  Effects of glycosylation of hypoglycaemic drug binding to serum albumin , 1997, Biopharmaceutics & drug disposition.

[56]  Mamoru Takahashi,et al.  An enzymatic method for the measurement of glycated albumin in biological samples. , 2002, Clinica chimica acta; international journal of clinical chemistry.